Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells

Atherosclerosis

Volumn 130, Issue 1-2, 1997, Pages 121-131

  Seewald, Stefan ^a   Sachinidis, Agapios ^a   Düsing, Rainer ^a   Ko, Yon ^a   Seul, Claudia ^a   Epping, Petra ^a   Vetter, Hans ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

cell number; cytosolic free calcium concentration; DNA synthesis; lysophosphatidic acid; MAP kinase; Na+ H+ antiport; pertussis toxin

Indexed keywords

LYSOPHOSPHATIDIC ACID; PERTUSSIS TOXIN;

ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; CALCIUM; CELL COUNT; CELL DIVISION; CELLS, CULTURED; CYTOSOL; DNA; HYDROGEN-ION CONCENTRATION; IMMUNOBLOTTING; LYSOPHOSPHOLIPIDS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUSCLE, SMOOTH, VASCULAR; PERTUSSIS TOXIN; PHOSPHORYLATION; PROTEIN KINASES; RATS; RATS, INBRED WKY; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER; VIRULENCE FACTORS, BORDETELLA;

EID: 0030972929     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06055-8     Document Type: Article

References (53)

1. Schwartz SM, Reidy M. Common mechanisms of proliferation of smooth muscle in atherosclerosis and hypertension. Hum Pathol 1987;18:240.
2. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res 1986;58:427.
3. Vidaver GA, Ting A, Lee JW. Evidence that lysolecithin is an important causal agent of atherosclerosis. J Theor Biol 1984;115:27.
4. Quinn MT, Parthasarathy S, Steinberg D. A chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA 1988;851:2805.
5. Nakona T, Raines EW, Abraham JA, Klagsbrun M, Ross R. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc Natl Acad Sci USA 1994;91:1069.
6. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induced mononuclear leucocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992;90:1138.
7. Kume N, Gimbrone MA Jr. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 1994;93:907.
8. Ylä-Herttuala S, Sumuvuori H, Karkola K, Möttönen M, Nikkari T. Atherosclerosis and biochemical composition of coronary arteries in Finnish men. Atherosclerosis 1987;65:109.
9. Locher R, Weisser B, Mengden T, Brunner C, Vetter W. Lysolecithin actions on vascular smooth muscle cells. Biochem Biophys Res Commun 1992;183:156.
10. Eichholtz, T, Jalink K, Fahrenfort I, Moolenaar, WH. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 1993;291:677.
11. Schumacher KA, Classen HG, Späth M. Platelet aggregation evoked in vitro and vivo by phosphatidic acids and lysoderivates: identity with substances in aged serum (DAS). Thromb Haemost 1979;42:631.
12. Tokumura A, Fukuzawa K, Yamada S, Tsukatani H. Stimulatory effect of lysophosphatidic acids on uterine smooth muscles of non-pregnant rats. Arch Int Pharmacodyn 1980;245:74.
13. Moolenaar WH, Kruijer W, Tilly BC, Verlaan I, Bierman AJ, de Laat SW. Growth factor-like action of phosphatidic acid. Nature, 1986;323:171.
14. Siegmann DW. Stimulation of quiescent 3T3 cells by phosphatidic acid-containing liposomes. Biochem Biophys Res Commun 1987;145:228.
15. Yu CL, Tsai MH, Stacey DW. Cellular ras activity and phospholipid metabolism. Cell 1988;52:63.
16. Van Corven EJ, Groenink A, Jalink K, Eichholtz T, Moolenaar, WH. Lysophosphatidate-induced cell proliferation: identification and dissection of signalling pathways mediated by G protein. Cell 1989;59:45.
17. 2+-mobilizing stimulus for fibroblasts. Evidence for an extracellular site of action. J Biol Chem 1990;265:12232.
18. ras by G protein-coupled receptor agonists in fibroblasts. Proc Natl Acad Sci USA 1993;90:1257.
19. Seufferlein T, Rozengurt E. Lysophosphatidic acid stimulates tyrosine phosphorylation of focal adhesion kinase, paxillin, and p 130. J Biol Chem 1994;269:9345.
20. Chamley JH, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev 1979;39:1.
21. Ross RJ. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fiber. J Cell Biol 1971;50:172.
22. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440.
23. Berk BC, Brock TA, Gimbrone MA Jr, Gragoe E Jr, Alexander WR. Early agonist-mediated ionic events in cultured vascular smooth muscle cells. J Biol Chem 1987;262:5065.
24. Simm A, Hoppe V, Tatje D, Schenzinger A, Hoppe J. PDGF-AA effectively stimulates early events but has no mitogenic activity in AKR-2B mouse fibroblasts. Exp Cell Res 1992;201:192.
25. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248.
26. Marshall CJ. Specifity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80:179.
27. Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 1995;80:225.
28. Sachinidis A, Locher R, Vetter W, Tatje D, Hoppe J. Different effects of PDGF-isoforms on rat vascular smooth muscle cells. J Biol Chem 1990;265:10238.
29. Pelech SL, Sanghera S. MAP kinases: charting the regulatory pathways. Science 1992;257:1355.
30. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801.
31. 2 and vascular smooth muscle cell proliferation. Hypertension 1995;26:771.
32. Gordeladze JO, Johanson PW, Paulssen RH, Paulssen EJ, Gautvik KM. G-Proteins: implication for pathophysiology and disease. Eur J Endocrinol 1994;131:557.
33. Hepler JR, Gilman AG. G proteins. Trends Biochem Sci 1992;17:383.
34. Sternweis PC, Smrcka AV. Regulation of phospholipase C by G proteins. Trends Biochem Sci 1992;17:502.
35. 2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells. Atherosclerosis 1994;112:69.
36. Tokumara A, Iimori M, Nishioka Y, Kitahara M, Sakashita M, Tanaka S. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am J Physiol 1994;267:C204.
37. Daemen MJA, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991;68:450.
38. Sachinidis A, Ko Y, Weisser P, Meyer zu Brickwedde MK, Düsing R, Christian R, Wieczorek AJ, Vetter H. EXP3174, a metabolite of Losartan (MK 954, DuP 753) is more potent than Losartan in blocking the angiotensin II-induced responses in vascular smooth muscle cells. J Hypertens 1993;11:155.
39. Bihoreau C, Monnot C, Davies E, Teutsch B, Bernstein K, Corvol P, Clauser E. Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. Proc Natl Acad Sci USA 1993;90:5133.
40. Berk BC, Brock TA, Gimrone MA Jr, Alexander WR. Early Agonist-mediated ionic events in cultured vascular smooth muscle cells. J Biol Chem 1987;262:5065.
41. Sage SO, Jobson TM, Rink TJ. Agonist-evoked changes in cytosolic calcium concentration in human platelets: studies in physiological bicarbonate. J Physiol London 1990;420:31.
42. 2+ in response in human platelets. Am J Physiol 1994;267:C1543.
43. Duff JL, Berk BC, Corson MA. Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 1992;188:257.
44. L'Allemain G, Pouyssegur J, Weber MJ. p42/Mitogen-activated protein kinase as a converging target for different growth factor signaling pathway: use of pertussis toxin as a discrimination factor. Cell Regul 1991;2:675.
45. raf-1. J Biol Chem 1993;268:20717.
46. Griendling KK, Rittenhouse SE, Brock TA, Ekstein LS, Gimbrone MA Jr, Alexander RW. Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem 1986;261:5901.
47. + exchanger in vascular smooth muscle cells. J Biol Chem 1987;267:14134.
48. Kanthou C, Parry G, Wijelath E, Kakkar VV, Demoliou-Mason C. Thrombin-induced proliferation and expression of platelet-derived growth factor-A chain gene in human vascular smooth muscle cells. FEBS Lett 1992;314:143.
49. Chambard CJ, Paris S, L'Allemain G, Pouysségur J. Two growth signalling pathways in fibroblasts distinguished by pertussis toxin. Nature 1987;326:800.
50. Vouret-Craviary V, Van Obberghen-Schilling E, Rasmusen UB, Paviariny A, Lecocq JP, Pouysségur J. Synthetic alpha-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis. Mol Biol Cell 1992;3:95.
51. Simon MI, Stratmann MP, Gautam N. Diversity of signal transduction. Science 1991; 252:802.
52. 2+ mobilization in vascular smooth muscle utilizes a slowly ribosylating pertussis toxin-sensitive G protein. J Biol Chem 1992;267:7295.
53. Socorro L, Alexander RW, Griendling KK. Cholera toxin modulation of angiotensin II-stimulated inositol phosphate production in cultured vascular smooth muscle cells. Biochem J 1990;265:799.